Physician profile
Marjorie A Demund
NPI 1063464873
$14,208.96
in general payments reported to CMS, 2019-2025
18 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.21 · 2020: $27.54 · 2021: $13K · 2022: $400 · 2023: $412 · 2024: $165 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,655.99 | 2021 | |
| Abbvie INC. | $278.72 | 2020-2023 | Orilissa |
| Astellas Pharma US INC | $183.30 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $179.98 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $160.62 | 2022-2024 | Ova1 |
| Meditrina | $151.90 | 2022 | |
| Hologic Sales and Service, LLC | $121.43 | 2021-2025 | Acessa Provu System, Aptima, Novasure |
| Biogen, INC. | $106.12 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $65.93 | 2019-2022 | |
| Exeltis, USA INC. | $56.69 | 2020-2025 | Slynd |
| Avion Pharmaceuticals | $51.15 | 2021-2022 | |
| Pfizer INC. | $46.43 | 2023-2024 | |
| Ethicon US, LLC | $38.51 | 2025 | Stratafix, Vistaseal, Dermabond |
| Amgen INC. | $31.78 | 2025 | Evenity |
| Organon LLC | $29.07 | 2023-2024 | Nexplanon |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $20.58 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Shield Therapeutics INC | $15.55 | 2024 | |
| Mylan Pharmaceuticals INC. | $15.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Demund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.